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Abstract
Purpose of Review This paper sought to provide rationale for determining when a patient with symptomatic peripheral artery
disease (PAD) might be referred for home-based versus facility-based exercise therapy.
Recent Findings Multiple randomized controlled studies have embedded supervised, structured exercise therapy as a class
IA recommended therapy for those with symptomatic PAD. More recently, there is interest in non-facility-based exercise
training as an alternative. The current literature is mixed on the effectiveness of non-facility-based training and is influenced
by the amount of contact with clinical staff providing some supervision (e.g., occasional facility-based exercise or coaching
phone calls), and the intensity (e.g., performed intermittently by inducing pain or continually and not inducing pain) and
frequency (e.g., 12-week common supervised exercise program or those longer than 24 weeks) of exercise. Certainly, the data
suggests non-facility-based exercise, while possibly improving walking performance, is inferior to facility-based supervised
exercise training. Comprehensive data is lacking on utilization of supervised exercise therapy in those with symptomatic
PAD, but is likely <2% of those eligible who participate. This suggests a possible important role for alternatives including
non-facility-based (e.g., home, fitness center).
Summary Exercise training in the supervised, facility-based setting appears to be greatly underutilized. Non-facility-based
exercise may help to overcome some of the most common barriers to participating in facility-based exercise including those
related to motivation, transportation, and proximity. However, facility-based training is considered the gold standard so
decisions about allowing a patient to exercise train at home must take into account issues including disease severity, patient
motivation and available exercise resources, mobility and balance, cognitive function, and other medical concerns (e.g.,
symptomatic coronary artery disease or heart failure).
Keywords Symptomatic · Peripheral artery disease · Facility-based · Exercise training

Introduction
Patients with symptomatic peripheral artery disease (PAD)
(e.g., claudication) that limits walking performance (i.e.,
walking time/distance to initial claudication discomfort and
maximal tolerable waking time/distance) should be treated
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with multiple guideline-directed medical therapies including, when indicated, medications, risk factor counseling and
control, revascularization, and exercise therapy [1]. Supervised exercise therapy (SET) performed at a medical facility or clinic is considered the gold standard for improving
walking performance in those with symptomatic PAD and
has a class IA rating based on the highest level of available research evidence [1]. Therefore, when possible, SET
should be the preferred mode of delivering exercise therapy.
However, the recent SARS-CoV-2 pandemic, combined with
an understanding that SET is not widely available throughout the USA, has resulted in clinicians who deliver exercise
therapy to consider non-facility-based (i.e., home or community) setting options.
An example of the development of non-facility-based
exercise has taken place within cardiac rehabilitation
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(CR). Since inception in the 1970s, through expansion in
the 1980s and 1990s, and to today’s delivery in more than
800 programs throughout the USA [2], the primary mode
of delivery has been in the medical facility setting (i.e.,
facility-based). These are typically located in hospitals
or clinics, with much fewer located in fitness facilities or
other non-medical buildings. Estimated participation in
cardiac rehabilitation is in the range of <20% for Medicare
eligible patients and has remained relatively unchanged
over the past 15–20 years [3, 4], to approximately 28%
among all eligible patients [2]. Recognizing the underutilization of cardiac rehabilitation (which is a class 1
(strong) or 2a (moderate) ACC/AHA recommendation for
many cardiac conditions [5]), the Million Hearts initiative
launched an effort to increase participation to 70% of eligible patients [6]. Additionally, there are many programmatic (e.g., quality initiatives, resource development) [7]
and research efforts [8] ongoing which are designed to
increase CR participation and adherence. As part of these
efforts, there has been an emphasis on non-facility-based
or hybrid (i.e., part facility and part home or other location) CR delivery. Much of this is done using synchronous
audio + video visits where CR staff can supervise one or
several patients exercising in a remote setting [9]. In addition to an ongoing NIH funded trial [8], there are many
programs offering this mode of CR delivery to Medicare
eligible patients during the COVID-19 pandemic. This is
primarily due to a temporary allowance of reimbursement
for this specific telehealth service by Medicare under their
“hospital without walls” program developed in response
to the declared public health emergency related to the
COVID pandemic (at the time of this writing, it is set to
expire on 12/31/2022 or when the public health emergency
is over, whichever comes first). This reimbursement allowance for those eligible for cardiac rehabilitation does not
apply to those with symptomatic PAD.
For the CR eligible patients, consideration must
occur as to which patients might be best suited for nonfacility-based CR. Factors related to telehealth accessibility, safety, effectiveness, etc. must be considered
to appropriately select these patients. Additionally, traditional facility-based CR participation barriers (e.g., cost,
transportation, fear of exercise after cardiac event) should
also be part of the decision process. Similar decisions
should be assessed and developed for patients with symptomatic PAD who are referred for SET. Can any of these
patients be recommended for non-facility-based structured
exercise training? This paper explores the effectiveness of
non-facility-based exercise training in patients with symptomatic PAD and presents factors that should be considered when recommending patients for non-facility-based
exercise training.
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Effectiveness of Facility‑Based Supervised
Exercise Training Versus Non‑Facility‑Based
Training
Supervised, structured exercise therapy is a treatment that
is developed and monitored by an exercise professional
(e.g., clinical exercise physiologist or a registered nurse
with exercise training experience) and provides a designed
and organized process of delivering an exercise dose, monitoring for improvement, and adjusting the workload to
maximize improvement. This type of exercise training has
consistently been shown to improve walking performance
in those who have PAD resulting in intermittent claudication [10–12]. For instance, Murphy et al. [12] randomized
111 patients with aortoiliac peripheral disease to either
optimal medical therapy (OMT), OMT plus revascularization, or OMT plus SET. SET was performed 3 times per
week for 26 weeks with a progressive treadmill walking
speed and grade adaptation based on patient walking performance. At 6 months, SET had the greatest improvement in peak treadmill walking time (5.8 ± 4.6 min) versus
revascularization (3.7 ± 4.9) and OMT (1.2 ± 2.6).
McDermott et al. [11] reported a significant improvement in 6-min walk distance (33.6 m, 95% CI, 9.4, 57.5)
in a supervised exercise group (n = 53) compared to a nonexercise control group (n = 51). The SET group performed
progressive intensity treadmill waking 3 times per week
for 6 months while the control group received weekly educational lectures over the same period.
Fakhry et al. [10] randomized 151 patients to either
SET or endovascular revascularization. The SET program
was 24 weeks in duration and consisted of treadmill walking, twice per week for 30 min per session, with encouragement to walk on their own for 60 min per day following
the SET program. The study team reported short (1 year)
and sustained (7 years) improvements in graded treadmill walking performance (maximal walking distance)
of 1041 m (95% CI 892, 1189) and 975 m (772, 1177),
respectively. Durable results were also found for pain-free
walking distance (916 m [743, 1090] and 700 m [461,
941]), respectively at 1-year and 7-year follow-up. These
improvements were not different versus revascularization.
Additionally, several meta-analyses have shown consistent improvements in walking performance associated with
SET [13–19] and emerging evidence suggests performing
SET following a percutaneous revascularization intervention will maximize results compared to either treatment
in isolation [20•].
Non-facility-based exercise is a potential alternative to
SET. Structured non-facility-based exercise training has
been shown to improve walking performance. Gardner
et al. [21] performed a randomized, controlled clinical trial
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comparing changes in functionality in patients with symptomatic PAD who performed exercise either in a supervised setting (n = 33), at home (i.e., non-facility; n = 29),
or neither (n = 30). The home-based exercise intervention
was structured with a goal of similar intensity, frequency,
and duration as the supervised group. Notably, to achieve
the goal of similar exercise volume, the home-based group
planned to exercise 5 min longer than the supervised group
because exercise intensity was lower at home. The authors
stated it was not their intention to duplicate the supervised
program at home and allowed for differences in walking
intensity. Patients at home could freely choose their walking pace while those exercising in the supervised setting
performed a traditional walk-pain-rest-walk-repeat protocol with incremental increases in intensity as indicated.
This study reported no difference in adherence to the
exercise training with both groups exceeding 80% attendance. Both groups similarly increased time to pain onset
and peak walking time. The author group stated that they
remained in regular contact (bi-weekly, 15-min meetings)
with the home-based group and monitored their ambulation and provided feedback and that this may be an important factor affecting their results [21].
McDermott et al. [22] evaluated if a wearable activity
monitor affected 6-min walk distance after 9 months of
intervention (4 weekly exercise visits at medical center in
the 1st month; wearable activity monitor for use at home;
weekly to bi-weekly coaching calls aimed at structured
exercise). This group was compared to a group receiving
no onsite exercise sessions or coaching interventions. The
primary finding was no difference in 6-min walk distance
between the groups after 9 months (−8.9 m, 95% CI, −26.0,
8.2; p = 0.31).
In a different study, McDermott et al. [23•] compared a
low-intensity versus a high-intensity home-based exercise
program in 305 patients with symptomatic PAD. The lowintensity group walked without ischemic pain at all times
while the high-intensity group was instructed to walk at a
pace that elicited moderate to severe pain, although it was
unclear if they performed a walk-rest-walk protocol. The
goal was to walk five times per week for up to 50 min over
a 12-month period. Six-minute walk distance was used to
evaluate walking performance change and the between group
comparison was −40.9 m (97.5% CI, −62, −21; p < 0.001)
for the low vs. high-intensity group (i.e., the high-intensity
group walked ~41 m more). The low-intensity group was
not different from a non-exercise control comparator group.
Several meta-analyses have evaluated non-facility-based
walking exercise versus supervised exercise. Pymer et al.
[24] evaluated 23 studies with 1907 study participants
and concluded that home-based exercise was inferior to
supervised exercise when maximal walking distance was
assessed (139 m difference; 95% CI 45, 232; p = 0.004). In a

sub-analysis of investigations in which monitoring was used
in non-facility-based settings, there was equivalent improvement in maximal walking distance (8 m difference; −81, 97;
p = 0.86).
Fokkenrood et al. [25] performed a Cochrane analysis of
14 studies (1202 male and female participants) comparing
supervised to non-supervised (defined as structured homebased exercise or walking advice) exercise programs. The
supervised setting was superior for improvement at both 3and
6 months of approximately 180 m in maximal treadmill walking distance. Pain-free treadmill walking distance was also
improved in the supervised setting. Another Cochrane review
compared supervised and home-based exercise [15]. They
included 21 studies with a total of 1400 participants where,
in general, exercise training was performed on 3 days each
week and follow-up at 6 weeks to 2 years. The supervised
groups had a 120 and 210-m improvement in maximal treadmill walking distance for SET compared to non-facility-based
training and walking advice alone, respectively, at 3 months
and were found to be durable at 6 and 12 months. The homebased group did not demonstrate an improvement in walking
performance. Interestingly, neither of these reviews found a
difference in quality-of-life assessment, but the quality of
this evidence was considered low. Finally, Back et al. [26]
assessed hospital-based versus home-based versus “go home
and walk advice”. They analyzed 9 studies (7 randomized
controlled and 2 non-randomized controlled trials) and considered the overall quality of the studies as low. Similar to
others, they found home-based was less effective for improving maximal and pain-free walking distances. However, they
reported that the home-based exercise appeared superior for
improvements in daily-life walking ability. They also stated
that both hospital-based and home-based structured exercise
were superior overall versus walking advice alone.
The general conclusion from these studies is that SET
should be used to elicit maximal walking performance
improvement. Note that many of the presented studies utilized a longer period of training (often 24 weeks or longer)
than the current typical duration of SET in a clinical setting
(12 weeks). Treat-Jacobson et al. reported the small mean
change in maximal walking distance for 8 studies that used
a 12-week training period (79% improvement) versus those
using a 24+ week training period (+92%) [27••]. This suggests that longer periods of training produce better improvement, so, when a supervised setting is not a viable option
due to either inability to participate or following maximum
duration participation, home-based exercise can be a viable
option for initial or continued walking performance improvements. However, for maximum benefit, a home-based program should be structured, supplemented with SET when
possible, and ideally provide connection to an exercise professional (e.g., phone consultation or coaching, ideally in
real-time) as often as possible.
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Typical Patients Referred to Supervised
Exercise Therapy

Determinants of Facility Versus
Non‑Facility‑Based Exercise Training

There has been only a small amount of evidence published on rates and characteristics of patients with
PAD referred for SET. Divakaran et al. [28] reviewed
all SET referrals in CMS-enrolled patients during the
first year of coverage of SET for patients with symptomatic PAD (June 1, 2017-December 31, 2018). Results
showed that of the 129,699 patients diagnosed with claudication, 1735 (1.3%) were enrolled in SET. Of those
enrolled, only 5% completed all 36 sessions; sixteen
was the median number of sessions completed. Patients
referred were predominantly older, white, and male, and
less likely to be dually enrolled in Medicaid, indicating higher socioeconomic status. However, there were
no differences between referred patients and a matched
group of non-referred patients in these characteristics.
As would be expected, SET-referred patients had high
rates of hypertension, hyperlipidemia, and history of
tobacco use, and these were similar to those in the nonreferred group. The majority of patients referred lived
in the Midwest (48%) and Northeast (16%), with underrepresentation in the South Atlantic and Southern regions
of the USA. During the 1-year follow-up period, SET
participants were significantly less likely to have surgical or endovascular revascularization compared to those
who were not referred (11.9 vs. 15.7% and 2.4 vs. 6.3%,
respectively).
The Patient-centered Outcomes Related to Treatment
Practices in Peripheral Arterial Disease (PORTRIAT) registry [29] found similar rates (2%) of referral in their US sites
during an earlier period (2011–2015) prior to CMS coverage
for SET. This contrasts with sites in the Netherlands that
averaged 70% referral to SET. It should be noted that SET
in the Netherlands has been well established and is covered
by health insurance.
One factor related to referral to SET is the lack of
available programs and lack of awareness of whether a
program is available in the community where a provider
practices. This likely influences what we know currently
about those referred and participating in SET. Dua et al.
[30] surveyed 900 vascular care physicians across the
USA regarding SET referral practices. Of the 135 (15%)
respondents, 49% had never referred a patient for SET,
30% were not aware that SET was covered by CMS, 52%
said that there was not a program available in their practice setting, and 34% did not know if a program was
available in their practice community. However, 98%
said that they would refer a patient if a program was
available.

To date, no study has been conducted that has specifically
investigated the appropriateness of facility-based SET
compared to non-facility-based exercise programs. Likewise, demographic and clinical predictors of response to
facility-based SET compared to non-facility-based exercise therapy programs are not well understood. Given this
lack of understanding, a collective decision between the
clinician and patient is recommended when deciding if a
facility-based SET or non-facility-based exercise program
is the most appropriate choice for the treatment of symptomatic PAD. It is well-documented that the clinicianpatient relationship plays a key role in the therapeutic
process and health service delivery through a unique
opportunity for a shared decision-making model [31,
32]. The model has three steps: (a) introducing choice
(facility-based SET vs. non-facility-based exercise), (b)
describing/detailing the options (i.e., how facility-based
SET and non-facility-based programs are implemented,
and which of these produce superior results), and (c) helping patients explore preferences and make decisions. Pertaining to the latter, the clinician and patient should evaluate factors that will ultimately affect (1) the safety of the
patient and (2) the feasibility of facility-based SET, which
will in turn directly influence program compliance and
outcomes. Following earlier discussion of the efficacy of
facility-based SET and non-facility-based exercise, here
we discuss the shared decision-making with a focus on
safety considerations and barriers to participation for both
rehabilitation options.
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Safety
A recent systematic review has now provided safety evidence of home-based exercise programs in persons with
symptomatic PAD [33]. In this review, twenty-seven studies were included and totaled 1642 participants completing 147,810 patient-hours of home-based exercise. Four
study-related (possibly or likely attributed to exercise
intervention) adverse events were reported, three of which
were cardiac in origin, giving an all-cause complication
rate of one event per 36,953 patient-hours. Three of these
events occurred following exercise inducing severe claudication pain (relative to exercise programs encouraging
bouts to mild or moderate pain). Each of the three studies
[21, 23 •, 34] within this systematic review from which
the four study-related adverse events occurred utilized
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symptom-limited graded exercise tests as part of the
screening process. It should be noted that the incidence
of adverse events in non-facility-based exercise programs
may result in the overestimation of safety due to three
factors. First, due to less monitoring used in non-facilitybased exercise programs relative to facility-based SET,
exercise is often completed at a self-selected pace (despite
prescribed intensity), and thus participants may be less
likely to experience an exercise-induced event. Likewise,
with the infrequent monitoring in most non-facility-based
exercise programs, it is plausible that events may not be
consistently reported by participants. Lastly, the number of
patient-hours reported in this review was calculated based
on the number and duration of training sessions prescribed
and not those completed.
Despite the limitations in the aforementioned review, the
current evidence suggests that non-facility-based exercise is a
safe exercise option for people with symptomatic PAD. However, there is currently no guidance for whom non-facility-based
exercise might be inappropriate (i.e., relative or absolute
contraindications). Currently the most relevant recommendations that might be used are those developed for non-facilitybased or hybrid-based cardiac rehabilitation programs [8]
and available safety exclusionary criteria from non-facilitybased exercise for PAD [22, 23•, 34, 35]. Since many patients
with PAD also have a cardiac condition, these recommendations are pertinent. Recent guidance related to safety considerations of hybrid-based cardiac rehabilitation (facility-based
[CR] + home-based CR) reveal contraindications for patients
who are (1) currently receiving continuous inotropic support,
(2) a recent recipient of a mechanical support device (i.e.,
LVAD), and (3) symptomatic (cardiac symptoms including
chest pain and dizziness) at very low workloads (≤ 2 metabolic equivalents of task) [8]. Likewise, current exclusionary
criteria in non-facility-based PAD exercise research protocols
often include critical limb ischemia (i.e., foot ulcers, gangrene,
ischemic pain at rest), revascularization procedure in the last
3 months, active cancer treatment, angina, NYHA class III or
IV heart failure, and inability to walk unaided [22, 23•, 34].
From these, a contraindication list for non-facility-based exercise was established and is reported in Table 1.
If a non-facility-based exercise program is considered
by the clinician and patient, the clinician should ensure the
following: (1) The patient is screened for comorbidities
that may make non-facility-based exercise unsafe or overly
challenging (Table 1) thereby making a facility-based SET
program the more appropriate option, and (2) a non-weight
bearing, symptom-limited graded exercise test is completed
in select patients with cardiac-related comorbidities including myocardial infarction in the past 12 months, history of
stable angina, heart failure, prior coronary revascularization,
prior heart valve repair or replacement, or heart transplant,
as recommended for facility-based SET programs [8]. If

Table 1  Safety indications to refer to facility versus non-facilitybased exercise for rehabilitation of symptomatic PAD
Chronic limb ischemia or CLI (ischemic rest pain, foot ulcer, or
gangrene)
Cognitive impairment (i.e., MCI, types of dementia)
Inability to walk unaided
Major gait or motor disturbance (i.e., Parkinson’s disease, MS, ataxia)
or other reasons for increased fall risk
Recent surgery
Angina/moderate-to-severe coronary artery disease
NYHA class III or IV heart failure
Recent recipient of mechanical support device (i.e., LVAD)
Receiving continuous inotropic support
Safety indications derived from recommendations for hybrid and
home-based exercise in cardiac rehabilitation and exclusionary criteria derived from home-based exercise studies in symptomatic PAD
SET supervised exercise therapy, PAD peripheral artery disease, CLI
critical limb ischemia, MCI mild cognitive impairment, MS multiple
sclerosis, NYHA New York Heart Association, LVAD left ventricular
assist device

safety concerns are expressed by the clinician, non-facilitybased exercise should not be considered, and facility-based
SET should be recommended to the patient and a referral
placed.
For patients deemed to be safe to participate in facility
or non-facility-based exercise, a discussion of feasibility
and barriers to each exercise delivery option should occur
as part of the shared decision-making process. Currently,
the primary barriers to use of facility-based SET programs
include the following: (1) travel (distance to facility-based
SET program or lack of transportation), (2) lack of available
SET programs (related to #1), (3) lack of patient interest or
motivation, and (4) cost of co-pay [28, 30, 36, 37]. With the
2017 CMS National Funding Determination to cover SET
for patients with lifestyle-limiting claudication set at ~$57
per session (about 50% of the CR payment), for many facilities, this reimbursement is insufficient to justify funding an
independent SET program. Thus, the majority (likely >80%)
of programs are embedded in CR programs [38]. The result
of this likely contributes to the barrier of insufficient availability of SET programs for participants. Lack of available
SET programs can contribute to travel concerns for all eligible patients. However, even if SET facilities are in relatively
close proximity, transportation (e.g., no car, expensive cab
service, public transportation not taking someone near a
facility) issues can still serve as a common barrier, particularly in urban settings. Due to lifestyle-limiting claudication,
eligible patients may find ambulating to transport hubs (i.e.,
bussing, light rail) to get to a SET facility to be challenging, especially in cold-weather climates. With regard to cost,
patients still may have a variable coinsurance fee for each of
the 36 SET sessions. For patients to have to pay three times
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Table 2  Barriers for facility-based SET and non-facility-based exercise participation for symptomatic PAD
Facility-based SET

Home-based exercise

Lack of available SET programs

Is over-ground walking a feasible option (weather or climate issues, lack
of facilities conducive for walking)?
Lack of aerobic exercise equipment

Travel (distance to facility-based SET program or lack of
transportation)
Lack of patient interest
Financial burden (cost of coinsurance fees, etc.)
COVID-19 fears
Family or employment obligations that interfere with the available
time slots for SET at the desired facility

Inability or lack of confidence to perform unsupervised exercise
rehabilitation for PAD
Past failures in starting and maintaining an exercise program

SET supervised exercise therapy, PAD peripheral artery disease, COVID-19 coronavirus disease 2019

per week for 12 weeks at a commonly seen 20% coinsurance
fee can experience an out-of-pocket cost (~$11.50 per session for up to 36 sessions [$414]) that is too costly to enroll
in SET and represents a socio-economical barrier.
Although barriers for participation in facility-based SET
are generally well understood, barriers for non-facility-based
exercise for treatment of symptomatic PAD are often under
recognized. Given that most non-facility-based exercise is
performed at home and utilizes over-ground walking, most
barriers for this form of exercise involve participation in
walking exercise, which include unsafe walking environment
conducive to falls, weather issues (heat/humidity and cold
Refer to facilitybased SET

Yes

extremes), unavailability of seating (for resting), and lack of
social support systems [39]. A summary of barriers for participation in facility-based and non-facility-based exercise
for symptomatic PAD is presented in Table 2.
The clinician’s knowledge of barriers for facility-based
and home-based exercise participation should be understood
to (1) inform their patient of these barriers (Table 2) and (2)
interview their patient to identify if any specific barriers are
present. A decision-making tool (Fig. 1) can aid the clinician
in guiding patient interviews to determine the appropriate
mode of rehabilitation for their patients with symptomatic
PAD.

Are contraindicaons for parcipaon in home-based exercise present?
No

Refer to facilitybased SET

No

Are common facility-based SET barriers present: 1) Is a SET program
available? 2) Is travel a barrier? 3) Is paent movated to do SET? 4) Will
insurance expenses (i.e., Co-Pay) be an issue?
Yes

Consider homebased program

No

Are potenal barriers to home-based exercise present: 1) Is aerobic
exercise equipment or seng to perform over-ground walking
available? 2) Is paent comfortable and knowledgeable to perform
unsupervised exercise? 3) Has paent struggled in the past with starng
and maintaining an exercise program (movaon)
Yes
Idenfy specific barrier and discuss with paent to come up with best
plan.

Fig. 1  Shared decision-making tree for determining use of facility-based SET or home-based exercise for PAD
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Conclusion
There are a variety of factors to consider when determining
the best location for an individual with symptomatic PAD
to perform their exercise training. The literature suggests
that exercising in a supervised setting will likely yield the
best results. However, non-facility-based (primarily home)
training can also provide positive results and should be considered when discussing with a patient. One possibility to
maximize non-facility-based exercise would be to implement using synchronous telehealth visits (ideally using both
audio and video connection) that would allow for real-time
supervision. A possible reason for this would be to ensure
adherence to the recommendation to stop exercise when
claudication pain increases to a mild or moderate level,
and to also ensure that progression occurs consistently when
indicated. However, the data needed to justify supervised
non-facility-based training does not yet exist and thus
whether these recommendations would be sufficient in the
non-facility-based setting is unknown. For this reason, currently if maximal improvement is desired, a facility-based
training model is likely best in most individuals.
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